REGISTER!

• NEW! UVM Medical Center - CVMC - Medical Oncologist / Hematologist - general oncology and hematology (benign and malignant disease) and includes inpatient consult service and outpatient clinics 
• Northern Light Health - Physician Medical Director -Oncology Service Line
• UVM Cancer Center / Larner College of Medicine 
• Academic clinician with experience in lung cancer, melanoma and immunotherapy - Assistant or Associate Professor in the Clinical Scholars Pathway
• Physician-scientist/academic clinician with experience in breast cancer - Associate Professor or Full Professor in the Clinical Scholar Pathway
• Classical hematologist - Assistant Professor, Associate Professor, or Professor in the Clinical Scholar Pathway
• DHMC Norris Cotton Cancer Center - oncologist positions at Dartmouth-Hitchcock Keene / Cheshire Medical Center, Dartmouth-Hitchcock Manchester & Concord, and Southwestern Vermont Regional Cancer Center

•  Northern Light Health Eastern Maine Medical Center - Clinical Research Nurse
• Northern Light Health Eastern Maine Medical Center - Board-certified/board eligible hematologist/oncologist
• New England Cancer Specialists - multiple positions

Register today to SAVE and for the best accommodations availability. Discounted Room Block Closes Monday, 9/26 Friday, 9/30

Learn more about our unique funding program! 

Join us in congratulating NAHPAC Special Award Recipients, Elizabeth McGrath and Nicole Messier! Saturday, September 10th, Nicole was recognized with a NAHPAC Distinguished Service Award, in recognition of her longstanding leadership as a co-chair of the committee, while Elizabeth was presented with a Founding Member Award, having served as a member of the committee since its founding in the fall of 2012. Thank you, Nicole and Elizabeth for your outstanding leadership and service to this important committee!

Please read this special message to our community.

Latest FDA Approvals

• Sept 21 - FDA approves selpercatinib for locally advanced or metastatic RET fusion-positive solid tumors
• Sept. 21 - FDA approves selpercatinib for locally advanced or metastatic RET fusion-positive non-small cell lung cancer
• Sept. 20 - FDA approves sodium thiosulfate to reduce the risk of ototoxicity associated with cisplatin in pediatric patients with localized, non-metastatic solid tumors
• Sept. 2nd - FDA approves durvalumab for locally advanced or metastatic biliary tract cancer
• August 26th - FDA Approves pemigatinib for relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement 
• August 24th - FDA approves ibrutinib for pediatric patients with chronic graft versus host disease, including a new oral suspension

Other Updates

• Cancer Screen Week - December 5-9

ASCO Survey on COVID in Oncology Registry

The aim is to help the cancer community learn more about the patterns of symptoms & severity of COVID among patients with cancer, as well as the impact on delivery of cancer care & patient outcomes. Periodic reports will deliver real-time information to the oncology community.

• ASCO Registry FAQs
• Enroll Your Practice
• Questions

ASCO COVID Resource Page

COVID Info & Resources including a Fact Sheet on EUA of BAmlanivimab